Back to Search
SETH COHEN, MD
MD
Emergency Medicine Physician
NPI: 1679151369Individual
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
U0567(TX)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis.
PMID 19180516·Arthritis Rheum·2009
4-observational
Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial.
PMID 18438830·Arthritis Rheum·2008
3-trial
Unresolved issues in identifying and overcoming inadequate response in rheumatoid arthritis: weighing the evidence.
PMID 19193621·J Rheumatol Suppl·2008
6-review
Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks.
PMID 16947627·Arthritis Rheum·2006
3-trial
Role of RANK ligand in normal and pathologic bone remodeling and the therapeutic potential of novel inhibitory molecules in musculoskeletal diseases.
PMID 16463406·Arthritis Rheum·2006
6-review
Etanercept treatment for autoimmune inner ear disease: results of a pilot placebo-controlled study.
PMID 16151336·Otol Neurotol·2005
2-rct
Patient- versus physician-reported outcomes in rheumatoid arthritis patients treated with recombinant interleukin-1 receptor antagonist (anakinra) therapy.
PMID 14997006·Rheumatology (Oxford)·2004
1-meta
The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis.
PMID 15172046·Rheum Dis Clin North Am·2004
6-review
A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate.
PMID 15082469·Ann Rheum Dis·2004
3-trial
Bringing the clinical experience with anakinra to the patient.
PMID 12817094·Rheumatology (Oxford)·2003
6-review
Interleukin 1 receptor antagonist anakinra improves functional status in patients with rheumatoid arthritis.
PMID 12563672·J Rheumatol·2003
3-trial
Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial.
PMID 11920396·Arthritis Rheum·2002
3-trial
Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
PMID 11592358·Arthritis Rheum·2001
3-trial
Two distinct ubiquitin-dependent mechanisms are involved in NF-kappaB p105 proteolysis.
PMID 16678126·Biochem Biophys Res Commun·2006
8-other
EMG biofeedback: the effects of CRF, FR, VR, FI, and VI schedules of reinforcement on the acquisition and extinction of increases in forearm muscle tension.
PMID 11680282·Appl Psychophysiol Biofeedback·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5323 HARRY HINES BLVD
DALLAS, TX 75390 - Phone
- (214) 648-3111
Quick Facts
- NPI
- 1679151369
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile